<DOC>
	<DOCNO>NCT00192712</DOCNO>
	<brief_summary>The study hypothesis chemoradiation base 2 drug improve local control long-term survival patient locally advanced pancreatic cancer . That gemcitabine irinotecan combine induction phase 2 month IrinoGem combination give 3 cycle , reduce dos , concurently irradiation .</brief_summary>
	<brief_title>Irinotecan , Gemcitabine Radiation Therapy Pancreatic Cancer</brief_title>
	<detailed_description />
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Irinotecan</mesh_term>
	<mesh_term>Camptothecin</mesh_term>
	<criteria>locally advanced pancreatic cancer performance status 02 normal blood count chemistry previous chemotherapy radiotherapy serious concurrent systemic disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2010</verification_date>
	<keyword>carcinoma</keyword>
	<keyword>pancreas</keyword>
	<keyword>chemotherapy</keyword>
	<keyword>radiotherapy</keyword>
</DOC>